Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.

نویسندگان

  • A Mygland
  • A Vincent
  • J Newsom-Davis
  • H Kaminski
  • F Zorzato
  • M Agius
  • N E Gilhus
  • J A Aarli
چکیده

BACKGROUND About 50% of patients with thymoma have paraneoplastic myasthenia gravis (MG). Myositis and myocarditis or neuromyotonia (NMT) will also develop in some. Patients with thymoma-associated MG produce autoantibodies to a variety of neuromuscular antigens, particularly acetylcholine receptor (AChR), titin, skeletal muscle calcium release channel (ryanodine receptor [RyR]), and voltage-gated potassium channels (VGKC). OBJECTIVE To examine whether neuromuscular autoantibodies in patients with thymoma correlate with specific clinical syndromes. METHODS Serum and plasma samples from 19 patients with thymoma-associated MG, of whom 5 had myositis and 6 had NMT, underwent testing for antibodies to AChR, titin, RyR, and VGKC. RESULTS Antibodies to AChR and titin were found in 19 and 17 patients, respectively. Antibodies to RyR correlated with the presence of myositis (P = .03); they were found in all 5 patients with myositis and in only 1 patient with NMT, but also in 4 of 8 patients with neither disease. Antibodies to VGKC were found in 4 patients with NMT, 1 of 3 patients undergoing testing for myositis, and 2 of 7 patients undergoing testing with neither comorbidity. Presence of RyR antibodies correlated with high levels of titin antibodies. CONCLUSIONS The results appear to distinguish partially between 3 groups of patients with thymoma-associated MG: the first with RyR antibodies and myositis or myocarditis, the second with NMT without RyR antibodies, and the third without RyR antibodies, myositis, or NMT. Differences in the thymoma may underlie these pathologic associations.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis

BACKGROUND Myasthenia gravis is an autoimmune neuromuscular disorder, which has only rarely been reported to co-manifest with myositis. The diagnosis of concomitant myositis in patients with myasthenia gravis is clinically challenging, and requires targeted investigations for the differential diagnosis, including EMG, autoantibody assays, muscle biopsy and, importantly, imaging of the mediastin...

متن کامل

Ocular Neuromyotonia and Myasthenia Gravis.

To the Editors: Myasthenia gravis presents with only ocular symptoms (diplopia, ptosis, and extraocular movement limitation) in approximately 20% of patients.1,2 Ocular myasthenia gravis is to be suspected in patients with intermittent diplopia with ophthalmoplegia that does not correspond to a single ocular motor nerve paresis. However, diplopia in only eccentric sustained gaze in myasthenia g...

متن کامل

Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis.

IMPORTANCE Acquired neuromyotonia is increasingly recognized as an autoimmune disorder, frequently associated with antibodies against voltage-gated potassium channel complex proteins.We present a case of acquired neuromyotonia as the heralding symptom of recurrent thymoma in a patient with myasthenia gravis. OBSERVATIONS A report of a single case of a 53-year-old man with myasthenia gravis an...

متن کامل

Case Report A Case of Myasthenia Gravis Associated with Thymoma, Multiple Schwannomas and Monoclonal IgA Gatnmopathy

Myasthenia gravis, malignant thymoma, multiple schwannomas and monoclonal IgA gammopathy coexisted in a 54-year-old Japanese man. Serum acetylcholine receptor antibody activity was located in the IgG fraction, but not in the paraprotein peak. It was speculated that all these disorders might fall under the spectrum of the diseases associated with thymic abnormality or that some growth factors mi...

متن کامل

Thymolipoma-associated Myasthenia Gravis with High Titer of Anti-MuSKAb: A Case Report

Myasthenia Gravis (MG) is a neuromuscular junction disorder caused by pathogenic autoantibodies to some parts of the post-synaptic muscle endplates. About 85% of generalized MG patients have autoantibodies against post-synaptic acetyl-choline receptors (AChR). From the 10-15% of the remaining patients, 45-50% are positive for Muscle Specific Tyrosine Kinase-Antibody (MuSK-Ab). It is believed th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Archives of neurology

دوره 57 4  شماره 

صفحات  -

تاریخ انتشار 2000